ESICM 2014: Intensivists Meet in Barcelona
Chiche noted that this congress marks the first time that a whole three sessions are devoted to randomised controlled trials (RCTs). Intensivists can be very proud of a field that is so dynamic and creative. he said.
In surveying the work of the Society, now with more than 7100 members, Chiche singled out the Society’s work on research and education.
Chiche commended the work of the ESICM Trials Group, which already includes more than 16000 patients in clinical trials. The Group holds a networking event on 30 September.
Chiche praised the NEXT programme, now two years old, which is developing the new generation of intensive care leaders. Due to launch in 2015 is the ICE-mentoring project, which will allow virtual mentoring.
ESICM Honorary Memberships were awarded to Julie Benbenishty (the first nurse to receive the honour), Veerappan Chithambaram and Arthur Slutsky. The ESICM medal went to Jukka Takala, who presented a review of his research into pathophysiology.
Derek Angus outlined what the next generation of clinical trials will look like - getting closer to individualised treatment decisions. Angus explained that the motivation for smart ‘adaptive’ trials is that they take advantage of accmulating data. Traditionally designed trials require all parameters to be fixed up front. This increases the risk of a failed trial, unnecessary patient exposure to harm and more. There are many uncertainties in designing a trial, such as optimal dose, duration, target population and so on. In an adaptive trial, however, information accumulates as patients are enrolled, and this information reduces uncertainty, and allows modification to trial parameters. Trial adaptations are pre-planned, well-defined, limited to key trial parameters and statistically valid. In adaptive trials, such information can be used to adapt for example, the target population, randomisation allocation, sample size, number of arms or primary outcome. Such adaptive trials have been conducted in oncology, and are now being conducted in the intensive care field. ESICM is the primary clinical research network for the PREPARE project, Platform FoR European Preparedndess Against (Re)emering Epidemics. PREPARE CAP is an adaptive trial that will determine the best care for severe acute respiratory failure of presumed infectious origin.
Published on : Sun, 28 Sep 2014
Print as PDF
Get an complete overview of your POCT setup - from one dashboard Your point-of-care-testing setup probably involves many different types of devices from various manufacturers. Radiometer's AQURE point-of-care management system can give you an overview...
Medos hemofilters pro are used for efficient and gentle hemofiltration during extracorporal circulation.Medos hemofilters pro do not need to be pre-flushed and can be used immediately. This guarantees a safe and quick hemofiltration.
The HAMILTON-C1 neo is a versatile neonatal ventilator that combines invasive and noninvasive modes with the additional options of nCPAP and high flow oxygen therapy. The integrated turbine allows it to be operated independently of a compressed air supply....
The HAMILTON-T1 combines for the first time the functionality of a fully featured intensive care unit ventilator with the compactness and ruggedness required for transport. This is why the HAMILTON-T1 enables you to provide optimal ventilation therapy...